Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors Meeting Abstract


Authors: Kezlarian, B.; Montecalvo, J.; Sauter, J.; Travis, W.; Gounder, M.; Rudin, C.; Ladanyi, M.; Namakydoust, A.; Rekhtman, N.
Abstract Title: Evaluation of H3K27me3 expression as a marker of EZH2 activation in SMARCA4/SMARCA2-deficient tumors and candidate biomarker for trials of EZH2 inhibitors
Meeting Title: 108th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP)
Journal Title: Laboratory Investigation
Volume: 99
Issue: Suppl. 1
Meeting Dates: 2019 Mar 16-21
Meeting Location: National Harbor, MD
ISSN: 0023-6837
Publisher: Nature Publishing Group  
Date Published: 2019-03-01
Start Page: 35
End Page: 36
Language: English
ACCESSION: WOS:000478081103335
PROVIDER: wos
PUBMED: 30886265
DOI: 10.1038/s41374-019-0227-8
Notes: Meeting Abstract: 1844 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    424 Rekhtman
  2. Marc Ladanyi
    1326 Ladanyi
  3. William D Travis
    743 Travis
  4. Mrinal M Gounder
    228 Gounder
  5. Charles Rudin
    488 Rudin
  6. Jennifer Lynn Sauter
    124 Sauter